The trajectory of companies tied to Sildenafil's legacy presents a intricate investment scenario . While the initial surge generated substantial profits , generic alternatives have significantly diminished https://bookmark-vip.com/story21732348/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-investment